Press Release: Revive Therapeutics Announces Research Collaboration with North Carolina State University for Natural Biosynthesis Enzymatic Platform To Develop Psilocybin

CANNANNEW REPORT

TORONTO, Jan.  14, 2021  (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company… Read More….. The post Press Release: Revive Therapeutics Announces Research Collaboration with North Carolina State University for Natural Biosynthesis Enzymatic Platform To Develop Psilocybin first appeared on Cannabis Law Report.

Excerpt only …
READ MORE BELOW
Source : Press Release: Revive Therapeutics Announces Research Collaboration with North Carolina State University for Natural Biosynthesis Enzymatic Platform To Develop Psilocybin

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.